Pseudomembranes on Colostomy

Jawa, Pankaj; Conlin, Frederick
March 2009
Mayo Clinic Proceedings;Mar2009, Vol. 84 Issue 3, p214
Academic Journal
The article focuses on the treatment process of a certain patient who was diagnosed with prostate cancer. The patient was said to be positive for Clostridium difficile toxin, and upon two days of hospitalization, yellow membranes were visible on the ostomy stump. The treatment option for pseudomembranous colitis is metronidazole, and vancomycin for repeated infection.


Related Articles

  • A Review on the Effects of Probiotics and Antibiotics towards Clostridium difficile Infections. Hazirah, A.; Loong, Y. Y.; Rushdan, A. A.; Rukman, A. H.; Yazid, M. M. // Pertanika Journal of Science & Technology;Jul2013, Vol. 21 Issue 2, p293 

    Clostridium difficile can cause severe diseases with significant morbidity and mortality in infected patients. The rate of Clostridium difficile infection is high in North America and European countries. Metronidazole and vancomycin have been recommended as the treatments of choice since 1990s....

  • Treatment of Pseudomembranous Colitis with Oral Metronidazole after Relapse Following Vancomycin. Oldenburger, Derek; Miller, Judith A. // American Journal of Gastroenterology;Oct1980, Vol. 74 Issue 4, p359 

    Presents information on a study regarding the treatment of pseudomembranous colitis with oral metronidazole after relapse following vancomycin. Use of oral vancomycin; Case history of a patient that was observed for the study; Exotoxin of Clostridium difficile.

  • The Changing Face of Clostridium difficile: What Treatment Options Remain? Shen, Edie P.; Christina, M. Surawicz // American Journal of Gastroenterology;Dec2007, Vol. 102 Issue 12, p2789 

    In this issue of the Journal, an article by Pepin et al. documents the shifting sands of the modern-day Clostridium difficile epidemic as seen in Quebec. Pepin and coauthors' observation that the superior activity of vancomycin over metronidazole has been lost since the emergence there of the...

  • Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile. Mathur, Tarun; Kumar, Manoj; Barman, Tarani K.; Kumar, G. Ram; Kalia, Vandana; Singh, Smita; Raj, V. Samuel; Upadhyay, Dilip J.; Das, Biswajit; Bhatnagar, Pradip K. // Journal of Antimicrobial Chemotherapy (JAC);May2011, Vol. 66 Issue 5, p1087 

    Objectives RBx 11760, a novel oxazolidinone, was investigated for in vitro and in vivo activity against Clostridium difficile. Methods The in vitro activity of RBx 11760 and three other agents against 50 diverse C. difficile clinical isolates and other obligate anaerobic bacteria was determined....

  • Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin. Lao, Dominador; Chiang, Tom; Gomez, Eric // Case Reports in Medicine;2012, p1 

    The occurrence of Clostridium difficile colitis is on the rise and has become more difficult to manage with standard therapy. Thus, the need for alternative treatments is essential. Tigecycline is a glycylcycline antibiotic that has been shown to be effective against C. difficile through several...

  • In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection. Chilton, C. H.; Crowther, G. S.; Baines, S. D.; Todhunter, S. L.; Freeman, J.; Locher, H. H.; Athanasiou, A.; Wilcox, M. H. // Journal of Antimicrobial Chemotherapy (JAC);Mar2014, Vol. 69 Issue 3, p697 

    Objectives We investigated the in vitro activity of cadazolid against 100 Clostridium difficile isolates and its efficacy in a simulated human gut model of C. difficile infection (CDI). Methods MICs of cadazolid, metronidazole, vancomycin, moxifloxacin and linezolid were determined using agar...

  • Critically Ill Patients With Clostridium difficile Infection: Are 2 Antibiotics Better Than One? Wilcox, Mark H. // Clinical Infectious Diseases;9/15/2015, Vol. 61 Issue 6, p942 

    The article focuses on the diagnosis and treatment of patients suffering with Clostridium difficile infection. It analyses the treatment of Clostridium difficile infection (CDI) with combination therapy with oral vancomycin and intravenous metronidazole in preference to vancomycin monotherapy....

  • Isolation and Characterization of a New Clostridium difficile Ribotype During a Prospective Study in a Hospital in Italy. Sisto, Francesca; Maraschini, Anna; Fabio, Giovanna; Serafino, Serena; Zago, Miriam; Scaltrito, Maria; Castaldi, Silvana // Current Microbiology;Feb2015, Vol. 70 Issue 2, p151 

    The article discusses the isolation and characterization of bacteria Clostridium difficile based on a prospective study done in a hospital in Milano, Italy. Topics include the identification of isolates through rapid ID 32A identification system and detection by enzyme-linked immunosorbent...

  • Treatment of Asymptomatic Clostridium difficile Carriers (Fecal Excretors) with Vancomycin or Metronidazole. Johnson, Stuart; Homann, Scott R.; Bettin, Kristine M.; Quick, Judith N.; Clabots, Connie R.; Peterson, Lance R.; Gerding, Dale N. // Annals of Internal Medicine;8/15/92, Vol. 117 Issue 4, p297 

    Compares the efficacy of vancomycin and metronidazole for eradication of asymptomatic Clostridium difficile (C. difficile) fecal excretion as a means of controlling nosocomial outbreaks of C. difficile diarrhea. Feasibility of the approach to controlling C. difficile disease in endemic or...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics